Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare lung disease characterised by progressive airflow obstruction. No effective medical treatment is available but therapy with sirolimus has shown some promise. The aim of this observational study was to evaluate sirolimus in progressive LAM. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Neurohr, Claus, Hoffmann, Anna L, Huppmann, Patrick, Herrera, Vivian A, Ihle, Franziska, Leuschner, Stefan, von Wulffen, Werner, Meis, Tobias, Baezner, Carlos, Leuchte, Hanno, Baumgartner, Rainer, Zimmermann, Gregor, Behr, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116484/
https://www.ncbi.nlm.nih.gov/pubmed/21600034
http://dx.doi.org/10.1186/1465-9921-12-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116484/
https://www.ncbi.nlm.nih.gov/pubmed/21600034
http://dx.doi.org/10.1186/1465-9921-12-66

Ejemplares similares